Amine Fluoride/Stannous Fluoride and Chlorhexidine Mouthwashes as Adjuncts to Single‐Stage Dental Implants: A Comparative Study
Authors:
- Jacob HorwitzJHJacob Horwitz
- Eli E. MachteiEMEli E. Machtei
- Otman ZuabiOZOtman Zuabi
- Micha PeledMPMicha Peled
- 1 March 2005
- journal article
- clinical trial
- Published by Wiley in Journal of Periodontology
- Vol. 76 (3) , 334-340
Abstract
Background: The growing popularity of non‐submerged dental implants in recent years requires a greater emphasis on microbial plaque control. Chlorhexidine (CHX), the most commonly used mouthwash in implant surgery, is sometimes associated with tooth staining and alteration in taste perception. Amine fluoride/stannous fluoride (AmF/SnF2) mouthwash has been shown to have anti‐infective properties; however, it has not been tested as an adjunct anti‐infective means in non‐submerged dental implants. The purpose of this trial was to compare AmF/SnF2 and CHX mouthwashes as adjuncts to single‐stage dental implants.Methods: Thirty‐three patients aged 34 to 79 (mean 54.30 ± 8.69 SD) requiring dental implants were accepted into the study. Following comprehensive periodontal therapy patients received one to three non‐submerged dental implants (maxilla: 17; mandible: 45; anterior: 3, posterior: 59). After surgery patients were given analgesics and antibiotics as well as 2,400 ml of coded mouthwash bottles previously randomized between the two above mentioned formulations. Clinical and radiographic parameters were recorded at baseline and 3 and 12 months post‐surgery.Results: Twelve‐month survival rates were 100% and 92.9% for the AmF/SnF2 and CHX groups, respectively. Compliance was slightly higher in the AmF/SnF2 group (84.35% ± 3.39% versus 78.15% ± 4.59% SE) but statistically similar. There was no statistically significant difference between the AmF/SnF2 and CHX groups in staining index at 3 months (1.519 ± 0.22 versus 1.457 ± 0.24 SE) and patient subjective evaluation of the mouthwashes. Radiographic bone loss was 0.79 ± 0.23 and 1 ± 0.13 SE at 3 months and 1.06 ± 0.13 and 1.27 ± 0.25 at 12 months for the CHX and AmF/SnF2 groups, respectively; the difference was statistically insignificant (P = 0.388 and 0.504, respectively).Conclusion: Both CHX and AmF/SnF2 mouthwashes can be used post‐surgically after one‐stage implant surgery. J Periodontol 2005;76: 334‐340.Keywords
This publication has 22 references indexed in Scilit:
- Clinical and Radiographic Evaluation of Soft and Hard Tissue Changes Around Implants: A Pilot StudyJournal of Periodontology, 2003
- Long‐term implant prognosis in patients with and without a history of chronic periodontitis: a 10‐year prospective cohort study of the ITI® Dental Implant SystemClinical Oral Implants Research, 2003
- Biologic outcome of implant‐supported restorations in the treatment of partial edentulismClinical Oral Implants Research, 2002
- Implant Survival in Patients With Type 2 Diabetes: Placement to 36 MonthsAnnals of Periodontology, 2000
- The Influence of Preoperative Antibiotics on Success of Endosseous Implants at 36 MonthsAnnals of Periodontology, 2000
- Amine Fluoride/Stannous Fluoride and Chlorhexidine Mouthwashes as Adjuncts to Surgical Periodontal Therapy: A Comparative StudyJournal of Periodontology, 2000
- A Prospective Multicenter Clinical Trial Comparing One‐ and Two‐Stage Titanium Screw‐Shaped Fixtures with One‐Stage Plasma‐Sprayed Solid‐Screw FixturesClinical Implant Dentistry and Related Research, 2000
- Evaluation of postsurgical crestal bone levels adjacent to non‐submerged dental implantsClinical Oral Implants Research, 1998
- Long-term Effects of Meridol® and Chlorhexidine Mouthrinses on Plaque, Gingivitis, Staining, and Bacterial VitalityJournal of Dental Research, 1993
- Efficacy of Listerine®, Meridol® and chlorhexidine mouthrinses on plaque, gingivitis and plaque bacteria vitalityJournal of Clinical Periodontology, 1990